INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Feb 07, 2012 |
SVP Finance and Admin CFO Trea
Trans History: 645
|
SVP Finance and Admin CFO Trea | Form 4 | Open market or private sale of non-derivative or derivative security | 13,265 | $99.67 | 91,346 |
May 21, 2020 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 13,268 | $564.62 | 374,219 |
Feb 17, 2016 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 13,288 | $395.32 | 23,338,947 |
Nov 05, 2015 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 13,312 | $567.63 | 64,130 |
Sep 18, 2013 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 13,346 | $304.38 | 364,913 |
Dec 15, 2016 |
Director, President & CEO
Trans History: 427
|
Director, President & CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 13,365 | $380.09 | 279,441 |
May 13, 2013 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Open market or private sale of non-derivative or derivative security | 13,378 | $276.71 | 58,648 |
May 06, 2013 |
SVP & General Mgr Industrial O
Trans History: 359
|
SVP & General Mgr Industrial O | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 13,450 | $260.44 | 24,461 |
May 07, 2013 |
Director, President Regeneron Laboratori
Trans History: 673
|
Director, President Regeneron Laboratori | Form 4 | Open market or private sale of non-derivative or derivative security | 13,457 | $261.66 | 1,192,938 |
Dec 04, 2023 |
EVP Research
Trans History: 222
|
EVP Research | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 13,464 | $813.58 | 65,957 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.